This patch usually expands in size and may take on an irregular, map-like pattern
Off-Label Dosing to Personalize GLP-1 Doses
Women-Centric GLP-1 Care: Prescribing access to FDA-approved weight-loss medications, with clinical decisions informed by reproductive history such as PCOS, postpartum recovery, perimenopause, and fertility considerations, rather than BMI alone
Compared with other antidiabetic or weight-reducing treatments, GLP-1 receptor agonists produced increased gonadotropins and sex hormone-binding globulin and improved erectile function, with serum androgen levels comparable to or exceeding those of other agents
When present, side effects are typically mild and transient, potentially including slight drowsiness if administered too early (easily resolved by timing adjustment), mild headaches during initial adaptation in some individuals (usually resolving within days), temporary vivid dreams as sleep architecture normalizes, or rare reports of mild dizziness upon waking in sensitive individuals
